Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration

Glioblastoma (GB) is the most common and the most aggressive form of brain tumor in adults, which currently lacks efficient treatment strategies. In this study, we investigated the therapeutic effect of function-blocking antibodies targeting integrin α10β1 on patient-derived-GB cell lines in vitro a...

Full description

Bibliographic Details
Main Authors: Katarzyna Chmielarska Masoumi, Xiaoli Huang, Wondossen Sime, Anna Mirkov, Matilda Munksgaard Thorén, Ramin Massoumi, Evy Lundgren-Åkerlund
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/5/1184
_version_ 1797542071587831808
author Katarzyna Chmielarska Masoumi
Xiaoli Huang
Wondossen Sime
Anna Mirkov
Matilda Munksgaard Thorén
Ramin Massoumi
Evy Lundgren-Åkerlund
author_facet Katarzyna Chmielarska Masoumi
Xiaoli Huang
Wondossen Sime
Anna Mirkov
Matilda Munksgaard Thorén
Ramin Massoumi
Evy Lundgren-Åkerlund
author_sort Katarzyna Chmielarska Masoumi
collection DOAJ
description Glioblastoma (GB) is the most common and the most aggressive form of brain tumor in adults, which currently lacks efficient treatment strategies. In this study, we investigated the therapeutic effect of function-blocking antibodies targeting integrin α10β1 on patient-derived-GB cell lines in vitro and in vivo. The in vitro studies demonstrated significant inhibiting effects of the integrin α10 antibodies on the adhesion, migration, proliferation, and sphere formation of GB cells. In a xenograft mouse model, the effect of the antibodies on tumor growth was investigated in luciferase-labeled and subcutaneously implanted GB cells. As demonstrated by in vivo imaging analysis and caliper measurements, the integrin α10-antibodies significantly suppressed GB tumor growth compared to control antibodies. Immunohistochemical analysis of the GB tumors showed lower expression of the proliferation marker Ki67 and an increased expression of cleaved caspase-3 after treatment with integrin α10 antibodies, further supporting a therapeutic effect. Our results suggest that function-blocking antibody targeting integrin α10β1 is a promising therapeutic strategy for the treatment of glioblastoma.
first_indexed 2024-03-10T13:24:28Z
format Article
id doaj.art-b3581f489cb440efbe16fd4a0fc34e8d
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T13:24:28Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-b3581f489cb440efbe16fd4a0fc34e8d2023-11-21T09:46:01ZengMDPI AGCancers2072-66942021-03-01135118410.3390/cancers13051184Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell MigrationKatarzyna Chmielarska Masoumi0Xiaoli Huang1Wondossen Sime2Anna Mirkov3Matilda Munksgaard Thorén4Ramin Massoumi5Evy Lundgren-Åkerlund6Xintela AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, SwedenXintela AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, SwedenIVRS AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, SwedenXintela AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, SwedenXintela AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, SwedenIVRS AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, SwedenXintela AB, Medicon Village, Scheeletorget 1, SE-223 81 Lund, SwedenGlioblastoma (GB) is the most common and the most aggressive form of brain tumor in adults, which currently lacks efficient treatment strategies. In this study, we investigated the therapeutic effect of function-blocking antibodies targeting integrin α10β1 on patient-derived-GB cell lines in vitro and in vivo. The in vitro studies demonstrated significant inhibiting effects of the integrin α10 antibodies on the adhesion, migration, proliferation, and sphere formation of GB cells. In a xenograft mouse model, the effect of the antibodies on tumor growth was investigated in luciferase-labeled and subcutaneously implanted GB cells. As demonstrated by in vivo imaging analysis and caliper measurements, the integrin α10-antibodies significantly suppressed GB tumor growth compared to control antibodies. Immunohistochemical analysis of the GB tumors showed lower expression of the proliferation marker Ki67 and an increased expression of cleaved caspase-3 after treatment with integrin α10 antibodies, further supporting a therapeutic effect. Our results suggest that function-blocking antibody targeting integrin α10β1 is a promising therapeutic strategy for the treatment of glioblastoma.https://www.mdpi.com/2072-6694/13/5/1184function-blocking antibodyglioblastomaintegrin α10β1collagenmigrationtumor growth
spellingShingle Katarzyna Chmielarska Masoumi
Xiaoli Huang
Wondossen Sime
Anna Mirkov
Matilda Munksgaard Thorén
Ramin Massoumi
Evy Lundgren-Åkerlund
Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
Cancers
function-blocking antibody
glioblastoma
integrin α10β1
collagen
migration
tumor growth
title Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
title_full Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
title_fullStr Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
title_full_unstemmed Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
title_short Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
title_sort integrin α10 antibodies reduce glioblastoma tumor growth and cell migration
topic function-blocking antibody
glioblastoma
integrin α10β1
collagen
migration
tumor growth
url https://www.mdpi.com/2072-6694/13/5/1184
work_keys_str_mv AT katarzynachmielarskamasoumi integrina10antibodiesreduceglioblastomatumorgrowthandcellmigration
AT xiaolihuang integrina10antibodiesreduceglioblastomatumorgrowthandcellmigration
AT wondossensime integrina10antibodiesreduceglioblastomatumorgrowthandcellmigration
AT annamirkov integrina10antibodiesreduceglioblastomatumorgrowthandcellmigration
AT matildamunksgaardthoren integrina10antibodiesreduceglioblastomatumorgrowthandcellmigration
AT raminmassoumi integrina10antibodiesreduceglioblastomatumorgrowthandcellmigration
AT evylundgrenakerlund integrina10antibodiesreduceglioblastomatumorgrowthandcellmigration